FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W3000252084> ?p ?o ?g. }

• W3000252084 abstract "Occurring against the backdrop of an overdose crisis, stimulant use and stimulant-involved deaths in North America are increasing at an alarming rate. Many of these deaths are being attributed to fentanyl and related analogs, which have been increasingly found within street-level stimulant supplies. Within this, people experiencing socio-economic marginalization are at the greatest risk of overdose and other harms from adulterated stimulants. Current treatments for stimulant use disorder have limited effectiveness, and even less applicability to the lived realities of marginalized stimulant users. Emerging technologies, such as drug checking, are being implemented to support safer stimulant use, but the accessibility and utility of these technologies to stimulant users are framed by experiences of vulnerability that render them largely ineffective.Solutions that provide a legal and safe supply of non-adulterated stimulants of known quality, and within a health care framework, are needed to directly address the risk of an increasingly adulterated stimulant supply. Similar innovative opioid-focused interventions are being piloted with medications that have a similar pharmacological effect as their illicit counterparts. While there are currently no approved pharmacotherapies for stimulant use, research has demonstrated a number of stimulant medications that are promising substitutes for cocaine and methamphetamine use. Much like with opioid-focused pharmacotherapies, having a consistent and safe supply of stimulants can lead to improved health outcomes and will drastically reduce overdose risk. However, for a stimulant safe supply intervention to be a success, it must provide the high and performance-enhancing effects that people seek from the illicit market, which requires doses and user agency that trials to date have not provided.Efforts are needed to investigate the feasibility of pharmacological stimulant-based interventions that address safe supply needs. The promise of similar opioid-focused approaches in addressing both overdose-related risks and experiences related to vulnerability underscores the need to advance safe supply approaches targeted towards people who use stimulants. Given the current overdose crisis and rising stimulant use across North America, the implementation and evaluation of such novel stimulant-focused interventions should be a public health priority." @default.
• W3000252084 created "2020-01-23" @default.
• W3000252084 creator A5047610685 @default.
• W3000252084 creator A5051015794 @default.
• W3000252084 creator A5051693569 @default.
• W3000252084 creator A5053342778 @default.
• W3000252084 creator A5076437004 @default.
• W3000252084 date "2020-01-10" @default.
• W3000252084 modified "2023-09-29" @default.
• W3000252084 title "Stimulant safe supply: a potential opportunity to respond to the overdose epidemic" @default.
• W3000252084 cites W1510604256 @default.
• W3000252084 cites W1816695864 @default.
• W3000252084 cites W2010098953 @default.
• W3000252084 cites W2015100978 @default.
• W3000252084 cites W2051366813 @default.
• W3000252084 cites W2060317088 @default.
• W3000252084 cites W2081935098 @default.
• W3000252084 cites W2097787837 @default.
• W3000252084 cites W2107871836 @default.
• W3000252084 cites W2113983839 @default.
• W3000252084 cites W2114469645 @default.
• W3000252084 cites W2152072422 @default.
• W3000252084 cites W2315152690 @default.
• W3000252084 cites W2325319684 @default.
• W3000252084 cites W2342724199 @default.
• W3000252084 cites W2435538831 @default.
• W3000252084 cites W2529189327 @default.
• W3000252084 cites W2608446001 @default.
• W3000252084 cites W2622394398 @default.
• W3000252084 cites W2778431906 @default.
• W3000252084 cites W2794387073 @default.
• W3000252084 cites W2794764561 @default.
• W3000252084 cites W2809363364 @default.
• W3000252084 cites W2884604272 @default.
• W3000252084 cites W2912640413 @default.
• W3000252084 cites W2922457650 @default.
• W3000252084 cites W2934837273 @default.
• W3000252084 cites W2940053455 @default.
• W3000252084 cites W2942772596 @default.
• W3000252084 cites W72313846 @default.
• W3000252084 doi "https://doi.org/10.1186/s12954-019-0351-1" @default.
• W3000252084 hasPubMedCentralId "https://www.ncbi.nlm.nih.gov/pmc/articles/6954588" @default.
• W3000252084 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/31924209" @default.
• W3000252084 hasPublicationYear "2020" @default.
• W3000252084 type Work @default.
• W3000252084 sameAs 3000252084 @default.
• W3000252084 citedByCount "45" @default.
• W3000252084 countsByYear W30002520842020 @default.
• W3000252084 countsByYear W30002520842021 @default.
• W3000252084 countsByYear W30002520842022 @default.
• W3000252084 countsByYear W30002520842023 @default.
• W3000252084 crossrefType "journal-article" @default.
• W3000252084 hasAuthorship W3000252084A5047610685 @default.
• W3000252084 hasAuthorship W3000252084A5051015794 @default.
• W3000252084 hasAuthorship W3000252084A5051693569 @default.
• W3000252084 hasAuthorship W3000252084A5053342778 @default.
• W3000252084 hasAuthorship W3000252084A5076437004 @default.
• W3000252084 hasBestOaLocation W30002520841 @default.
• W3000252084 hasConcept C118552586 @default.
• W3000252084 hasConcept C126322002 @default.
• W3000252084 hasConcept C138816342 @default.
• W3000252084 hasConcept C155164915 @default.
• W3000252084 hasConcept C159110408 @default.
• W3000252084 hasConcept C170493617 @default.
• W3000252084 hasConcept C27415008 @default.
• W3000252084 hasConcept C2778750930 @default.
• W3000252084 hasConcept C2779148768 @default.
• W3000252084 hasConcept C2779418921 @default.
• W3000252084 hasConcept C2780557958 @default.
• W3000252084 hasConcept C2781063702 @default.
• W3000252084 hasConcept C529928208 @default.
• W3000252084 hasConcept C71924100 @default.
• W3000252084 hasConcept C99454951 @default.
• W3000252084 hasConceptScore W3000252084C118552586 @default.
• W3000252084 hasConceptScore W3000252084C126322002 @default.
• W3000252084 hasConceptScore W3000252084C138816342 @default.
• W3000252084 hasConceptScore W3000252084C155164915 @default.
• W3000252084 hasConceptScore W3000252084C159110408 @default.
• W3000252084 hasConceptScore W3000252084C170493617 @default.
• W3000252084 hasConceptScore W3000252084C27415008 @default.
• W3000252084 hasConceptScore W3000252084C2778750930 @default.
• W3000252084 hasConceptScore W3000252084C2779148768 @default.
• W3000252084 hasConceptScore W3000252084C2779418921 @default.
• W3000252084 hasConceptScore W3000252084C2780557958 @default.
• W3000252084 hasConceptScore W3000252084C2781063702 @default.
• W3000252084 hasConceptScore W3000252084C529928208 @default.
• W3000252084 hasConceptScore W3000252084C71924100 @default.
• W3000252084 hasConceptScore W3000252084C99454951 @default.
• W3000252084 hasFunder F4320334506 @default.
• W3000252084 hasIssue "1" @default.
• W3000252084 hasLocation W30002520841 @default.
• W3000252084 hasLocation W30002520842 @default.
• W3000252084 hasLocation W30002520843 @default.
• W3000252084 hasLocation W30002520844 @default.
• W3000252084 hasLocation W30002520845 @default.
• W3000252084 hasOpenAccess W3000252084 @default.
• W3000252084 hasPrimaryLocation W30002520841 @default.
• W3000252084 hasRelatedWork W1577630651 @default.
• W3000252084 hasRelatedWork W2289181419 @default.
• W3000252084 hasRelatedWork W2561135550 @default.

• next